Founded in 2009, Nephroplus operates in Health Tech industry. Initially, it concentrated on expanding dialysis centers and offering patient-centric care, but has since evolved to become Indias largest...
Funding stage:
Series F
Last funding:
02/05/2024
Total funding:
$199.63 Mn+
Revenue:
Investors
Employee count:
2,010
Last 90d
2,010
Last 90d
Web traffic:
18.52K
18.52K
Last 30d
Last 30d
Glassdoor Rating:
Nephroplus: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders70
Latest Filing Date25 June 2025- Funding Events60
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Nephroplus
As of 26 June 2025, Nephroplus's equity is held by 67 shareholders, with the top three being Edoras Investment Holdings, Healthcare Parent, and Vikram Vuppala.
Edoras Investment Holdings holds the largest stake in Nephroplus at 23.9% as of 26 June 2025.
As of 26 June 2025, founders collectively hold 10.9% equity in Nephroplus.
As of 26 June 2025, investors collectively hold 63.2% equity in Nephroplus.
Nephroplus's ESOP pool stands at 6.7% of total equity as of 26 June 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links